John Lewicki
Förmögenhet: 31 932 $ per 2026-05-31
Förmögenhet: 31 932 $ per 2026-05-31
John A. Lewicki is Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Formerly, Dr. Lewicki was President, Chief Executive Officer & Director at Mereo BioPharma 5, Inc. from 2018 to 2019.
Prior to that, Dr. Lewicki was Principal at Scios, Inc. from 1983 to 2000.
Dr. Lewicki earned a doctorate from the University of California San Diego.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-01 | 464 130 ( 0,06 % ) | 31 932 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Teknisk/Vetenskaplig/F&U Direktör | 2020-07-01 |
| Företag | Position | Slut |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Verkställande Direktör | 2019-04-23 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån